Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012;13(2):2331-2353.
doi: 10.3390/ijms13022331. Epub 2012 Feb 21.

Epigenetic disregulation in oral cancer

Massimo Mascolo  1 , Maria Siano  1 , Gennaro Ilardi  1 , Daniela Russo  1 , Francesco Merolla  1 , Gaetano De Rosa  1   2 , Stefania Staibano  1
Affiliations
Review

Epigenetic disregulation in oral cancer

Massimo Mascolo et al. Int J Mol Sci. 2012.

Abstract

Squamous cell carcinoma of the oral region (OSCC) is one of the most common and highly aggressive malignancies worldwide, despite the fact that significant results have been achieved during the last decades in its detection, prevention and treatment. Although many efforts have been made to define the molecular signatures that identify the clinical outcome of oral cancers, OSCC still lacks reliable prognostic molecular markers. Scientific evidence indicates that transition from normal epithelium to pre-malignancy, and finally to oral carcinoma, depends on the accumulation of genetic and epigenetic alterations in a multistep process. Unlike genetic alterations, epigenetic changes are heritable and potentially reversible. The most common examples of such changes are DNA methylation, histone modification, and small non-coding RNAs. Although several epigenetic changes have been currently linked to OSCC initiation and progression, they have been only partially characterized. Over the last decade, it has been demonstrated that especially aberrant DNA methylation plays a critical role in oral cancer. The major goal of the present paper is to review the recent literature about the epigenetic modifications contribution in early and later phases of OSCC malignant transformation; in particular we point out the current evidence of epigenetic marks as novel markers for early diagnosis and prognosis as well as potential therapeutic targets in oral cancer.

Keywords: epigenetics; molecular therapy; oral cancer; prognosis; tumor progression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A case of aggressive squamous cell carcinoma of tongue, Human Papillomavirus (HPV)-negative, showing a strong expression of chromatin Assembly Factor-1 (CAF-1)/p60. The patient experienced two local recurrences, nodal and distant metastases and died for disease in a period between 1 and 3 years from diagnosis. In the higher magnification you can note most nuclei of tumor cells strongly immunostained for the protein (1A: original magnification × 200; 1B: original magnification × 250).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005;55:74–108. - PubMed
    1. Argiris A., Karamouzis M.V., Raben D., Ferris R.L. Head and neck cancer. Lancet. 2008;371:1695–1709. - PMC - PubMed
    1. Stewart B.W., Greim H., Shuker D., Kauppinen T. Defence of IARC monographs. Lancet. 2003;361 doi: 10.1016/S0140-6736(03).13003-6. - DOI - PubMed
    1. Mydlarz W.K., Hennessey P.T., Califano J.A. Advances and perspectives in the molecular diagnosis of head and neck cancer. Expert Opin. Med. Diagn. 2010;4:53–65. - PMC - PubMed
    1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008;58:71–96. - PubMed

Publication types